Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma.

Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. BMC Cancer (2016) 0.78

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27

Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet (2007) 15.46

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med (2002) 14.01

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood (2003) 13.92

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature (2005) 13.44

Biological robustness. Nat Rev Genet (2004) 9.98

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71

Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell (2005) 9.27

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature (2010) 8.78

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol (2009) 8.63

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell (2009) 8.33

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res (2008) 7.45

Oncogenically active MYD88 mutations in human lymphoma. Nature (2010) 7.34

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med (2001) 6.66

Roles for microRNAs in conferring robustness to biological processes. Cell (2012) 6.32

The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol (2010) 6.28

Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet (2011) 6.06

MicroRNA control of signal transduction. Nat Rev Mol Cell Biol (2010) 5.74

Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell (2008) 5.53

Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA (2008) 4.53

PI3 kinase signals BCR-dependent mature B cell survival. Cell (2009) 4.43

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell (2008) 4.01

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood (2007) 3.52

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A (1997) 3.40

Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol (2002) 3.27

Encoding and decoding cellular information through signaling dynamics. Cell (2013) 2.96

Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers. Cancer Cell (2012) 2.53

B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem (2007) 2.44

Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov (2013) 2.31

Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol (2011) 2.11

PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol (2002) 2.03

Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet (2011) 2.00

Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science (2013) 1.94

MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci U S A (2012) 1.89

miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood (2014) 1.82

Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood (2005) 1.78

RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J Immunol (2005) 1.70

PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochem J (2012) 1.56

MicroRNAs prevent the generation of autoreactive antibodies. Immunity (2010) 1.38

A high throughput experimental approach to identify miRNA targets in human cells. Nucleic Acids Res (2009) 1.24

Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res (2011) 1.23

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood (2014) 1.19

MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J Biol Chem (2013) 1.13

MicroRNAs trigger dissociation of eIF4AI and eIF4AII from target mRNAs in humans. Mol Cell (2014) 1.12

BCL6 positively regulates AID and germinal center gene expression via repression of miR-155. J Exp Med (2012) 1.11

The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosomes Cancer (2013) 1.09

Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood (2005) 1.08

MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia (2014) 1.08

Comprehending the complex connection between PKCbeta, TAK1, and IKK in BCR signaling. Immunol Rev (2009) 1.05

Screening for possible miRNA-mRNA associations in a colon cancer cell line. Gene (2013) 1.00

Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways. Blood (2010) 0.99

Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Genome Biol (2015) 0.99

Experimental identification of microRNA targets by immunoprecipitation of Argonaute protein complexes. Methods Mol Biol (2011) 0.98

The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. Blood (2013) 0.96

MicroRNA signatures in B-cell lymphomas. Blood Cancer J (2012) 0.95

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood (2014) 0.95

Dysfunction of phospholipase Cγ in immune disorders and cancer. Trends Biochem Sci (2014) 0.83

Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-kappaB inhibitor DHMEQ. Microbes Infect (2008) 0.83

Gastric Syphilis. Intern Med (2017) 0.75